STAT+: Roche pharmaceuticals CEO Bill Anderson to step down after four-year-tenure
Roche announced Monday that Bill Anderson, CEO of its pharmaceuticals division, will step down after nearly four years at the helm.
His last day will be Dec. 31, Roche said, as Anderson leaves to “pursue opportunities outside of Roche.” A successor will be appointed by March, the company added.
